Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines.

Source:http://linkedlifedata.com/resource/pubmed/id/20878959

Int. J. Cancer 2011 Jul 15 129 2 497-506

Download in:

View as

General Info

PMID
20878959